Literature DB >> 25869354

Predicting and treating stress-induced vulnerability to epilepsy and depression.

Christel Becker1,2,3,4, Elodie Bouvier1,2,3, Antoine Ghestem5,6, Safia Siyoucef5,6, Damien Claverie1,2,3,7, Françoise Camus1,2,3, Fabrice Bartolomei5,6, Jean-Jacques Benoliel1,2,3,8, Christophe Bernard5,6.   

Abstract

Accumulation of stressful events can render individuals susceptible to develop epilepsy and comorbidities. Whether such vulnerability can be predicted and reversed is not known. Here we show that social defeat, although not producing depression by itself, produced in 50% of rats reduced threshold for status epilepticus (SE), accelerated epileptogenesis, and once epilepsy was induced, depression-like profile and cognitive deficits. Low serum brain-derived neurotrophic factor (BDNF) levels measured before SE identified this vulnerable population. Treatment with a BDNF analog before SE prevented the occurrence of comorbidities. Thus, vulnerability to comorbidities after epilepsy onset due to unresolved past stressful events may be predicted and reversed.
© 2015 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25869354     DOI: 10.1002/ana.24414

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Primed for Problems: Stress Confers Vulnerability to Epilepsy and Associated Comorbidities.

Authors:  Jamie Maguire
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

2.  Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression.

Authors:  E Bouvier; F Brouillard; J Molet; D Claverie; J-H Cabungcal; N Cresto; N Doligez; C Rivat; K Q Do; C Bernard; J-J Benoliel; C Becker
Journal:  Mol Psychiatry       Date:  2016-09-20       Impact factor: 15.992

3.  Inherent vulnerabilities in monoaminergic pathways predict the emergence of depressive impairments in an animal model of chronic epilepsy.

Authors:  Jesús-Servando Medel-Matus; Don Shin; Raman Sankar; Andrey Mazarati
Journal:  Epilepsia       Date:  2017-06-09       Impact factor: 5.864

4.  BDNF and COMT, but not APOE, alleles are associated with psychiatric symptoms in refractory epilepsy.

Authors:  Christine Doherty; Olivia Hogue; Darlene P Floden; Jessica B Altemus; Imad M Najm; Charis Eng; Robyn M Busch
Journal:  Epilepsy Behav       Date:  2019-03-22       Impact factor: 2.937

Review 5.  The Diathesis-Epilepsy Model: How Past Events Impact the Development of Epilepsy and Comorbidities.

Authors:  Christophe Bernard
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

6.  2014 Epilepsy Benchmarks Area I: Understanding the Causes of the Epilepsies and Epilepsy-Related Neurologic, Psychiatric, and Somatic Conditions.

Authors:  Rochelle Caplan; Heather Mefford; Madison Berl; Bernard Chang; Jack Lin; Andrey Mazarati; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

7.  Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy.

Authors:  Udaya Kumar; Jesus-Servando Medel-Matus; Hannah M Redwine; Don Shin; Julie G Hensler; Raman Sankar; Andrey Mazarati
Journal:  Epilepsia       Date:  2016-01-27       Impact factor: 5.864

Review 8.  WONOEP appraisal: Molecular and cellular biomarkers for epilepsy.

Authors:  Lauren E Walker; Damir Janigro; Uwe Heinemann; Raili Riikonen; Christophe Bernard; Manisha Patel
Journal:  Epilepsia       Date:  2016-07-04       Impact factor: 5.864

Review 9.  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies.

Authors:  Catherine A Christian; Doodipala Samba Reddy; Jamie Maguire; Patrick A Forcelli
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

10.  Mechanisms of Psychiatric Comorbidities in Epilepsy.

Authors:  Jamie Maguire
Journal:  Curr Top Behav Neurosci       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.